Inhibition of peroxisome proliferator‐activated receptor gamma activity in esophageal carcinoma cells results in a drastic decrease of invasive properties
Authors:
Open Access
- 28 June 2006
- journal article
- Published by Wiley in Cancer Science
- Vol. 97 (9) , 854-860
Abstract
Esophageal cancer is difficult to treat because of its rapid progression, and more effective therapeutic approaches are needed. The PPARγ is a nuclear receptor superfamily member that is expressed in many cancers. PPARγ expression is a feature of esophageal cancer cell lines, and in the present investigation, the PPARγ antagonists T0070907 and GW9662 could induce loss of invasion but could not induce growth reduction or apoptosis at low concentrations (Cancer Sci 2006; 97: 854–860)Keywords
This publication has 30 references indexed in Scilit:
- Critical Role of Peroxisome Proliferator-Activated Receptor γ on Anoikis and Invasion of Squamous Cell CarcinomaClinical Cancer Research, 2005
- Therapeutic potential of thiazolidinediones as anticancer agentsExpert Opinion on Investigational Drugs, 2003
- Growth inhibition through activation of peroxisome proliferator-activated receptor γ in human oesophageal squamous cell carcinomaEuropean Journal of Cancer, 2003
- A Phase II Study of Troglitazone, an Activator of the PPAR?? Receptor, in Patients with Chemotherapy-Resistant Metastatic Colorectal CancerThe Cancer Journal, 2002
- Peroxisome Proliferator-Activated Receptor γ Induces Pancreatic Cancer Cell ApoptosisBiochemical and Biophysical Research Communications, 2001
- Ligands for Peroxisome Proliferator-Activated Receptor Inhibit Growth and Induce Apoptosis of Human Papillary Thyroid Carcinoma CellsThe Journal of Clinical Endocrinology & Metabolism, 2001
- Peroxisome Proliferator-Activated Receptors: Nuclear Control of MetabolismEndocrine Reviews, 1999
- Integrin SignalingScience, 1999
- Peroxisome Proliferator‐activated Receptor γ Induces Growth Arrest and Differentiation Markers of Human Colon Cancer CellsJapanese Journal of Cancer Research, 1999
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998